Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

Colaboración

Año: 2018

Perez-Valero, I; Pasquau, J; Rubio, R; Rivero, A; Santos, J; Sanz, J; Marino, A; Crespo, M; Hernandez-Quero, J; Iribarren, JA; Gutierrez, F; Terron, A; Esteban, H; Perez-Molina, JA

Título: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

• D1